Search

Your search keyword '"Brozek, Jan L"' showing total 12 results
Start Over Author "Brozek, Jan L" Publication Year Range Last 3 years
12 results on '"Brozek, Jan L"'

1. World Allergy Organization (WAO) Diagnosis and Rationale for Action against Cow's Milk Allergy (DRACMA) guideline update – XI – Milk supplement/replacement formulas for infants and toddlers with CMA – Systematic review

Author

Bognanni, Antonio, Firmino, Ramon T., Arasi, Stefania, Chu, Derek K., Chu, Alexandro W.L., Waffenschmidt, Siw, Agarwal, Arnav, Dziechciarz, Piotr, Horvath, Andrea, Mihara, Hanako, Roldan, Yetiani, Terracciano, Luigi, Martelli, Alberto, Starok, Anna, Said, Maria, Shamir, Raanan, Ansotegui, Ignacio J., Dahdah, Lamia, Ebisawa, Motohiro, Galli, Elena, Kamenwa, Rose, Lack, Gideon, Li, Haiqi, Pawankar, Ruby, Warner, Amena, Wong, Gary Wing Kin, Bozzola, Martin, Assa'Ad, Amal, Dupont, Christophe, Bahna, Sami, Spergel, Jonathan, Venter, Carina, Szajewska, Hania, Nowak-Wegrzyn, Anna H., Vandenplas, Yvan, Papadopoulos, Nikolaos G., Waserman, Susan, Fiocchi, Alessandro, Schünemann, Holger J., and Brożek, Jan L.

Published
2024
Full Text
View/download PDF

2. World Allergy Organization (WAO) Diagnosis and Rationale for Action against Cow's Milk Allergy (DRACMA) guideline update – XII – Recommendations on milk formula supplements with and without probiotics for infants and toddlers with CMA

Author

Bognanni, Antonio, Fiocchi, Alessandro, Arasi, Stefania, Chu, Derek K., Ansotegui, Ignacio, Assa'ad, Amal H., Bahna, Sami L., Berni Canani, Roberto, Bozzola, Martin, Dahdah, Lamia, Dupont, Christophe, Dziechciarz, Piotr, Ebisawa, Motohiro, Firmino, Ramon T., Chu, Alexandro, Galli, Elena, Horvath, Andrea, Kamenwa, Rose, Lack, Gideon, Li, Haiqi, Martelli, Alberto, Nowak-Węgrzyn, Anna, Papadopoulos, Nikolaos G., Pawankar, Ruby, Roldan, Yetiani, Said, Maria, Sánchez-Borges, Mario, Shamir, Raanan, Spergel, Jonathan M., Szajewska, Hania, Terracciano, Luigi, Vandenplas, Yvan, Venter, Carina, Waffenschmidt, Siw, Waserman, Susan, Warner, Amena, Wong, Gary W.K., Schünemann, Holger J., and Brozek, Jan L.

Published
2024
Full Text
View/download PDF

3. World Allergy Organization (WAO) Diagnosis and Rationale for Action against Cow's Milk Allergy (DRACMA) guideline update – XIII – Oral immunotherapy for CMA – Systematic review

Author

Ansotegui, Ignacio J., Arasi, Stefania, Assa'ad, Amal H., Bahna, Sami L., Canani, Roberto Berni, Bognanni, Antonio, Bozzola, Martin, Brozek, Jan, Chu, Derek K., Dahdah, Lamia, Dupont, Christophe, Ebisawa, Motohiro, Fiocchi, Alessandro, Firmino, Ramon Targino, Galli, Elena, Kamenwa, Rose, Lack, Gideon, Li, Haiqi, Martelli, Alberto, Nowak-Wegrzyn, Anna H., Papadopoulos, Nikolaos G., Pawankar, Ruby, Said, Maria, Sánchez-Borges, Mario, Schünemann, Holger J., Shamir, Raanan, Spergel, Jonathan M., Szajewska, Hania, Terracciano, Luigi, Vandenplas, Yvan, Venter, Carina, Warner, Amena, Waserman, Susan, Wong, GaryW.K., Firmino, Ramon T., Waffenschmidt, Siw, Agarwal, Arnav, Dziechciarz, Piotr, Horvath, Andrea, Jebai, Rime, Mihara, Hanako, Roldan, Yetiani, Bahna, Sami, and Brożek, Jan L.

Published
2022
Full Text
View/download PDF

4. Analytical frameworks in colorectal cancer guidelines: development of methods for systematic reviews, their application and practical guidance for their use

Author

Karam, Samer G., Darzi, Andrea J., Bognanni, Antonio, Morsi, Rami Z., Tannous, Elie E., Charide, Rana, Choe, Se-In, Stalteri, Rosa, Lee, Yung, Piggott, Thomas, Jewell, Laura, Schünemann, Finn, Langendam, Miranda, Parmelli, Elena, Saz-Parkinson, Zuleika, Roi, Annett, Vilahur, Nadia, Vali, Yasaman, Waffenschmidt, Siw, Owens, Douglas K., Leontiadis, Grigorios I., Moayyedi, Paul, Brozek, Jan L., and Schünemann, Holger J.

Published
2022
Full Text
View/download PDF

6. World Allergy Organization (WAO) Diagnosis and Rationale for Action against Cow’s Milk Allergy (DRACMA) Guideline update – XIV – Recommendations on CMA immunotherapy

Author

Brozek, Jan L., Firmino, Ramon T., Bognanni, Antonio, Arasi, Stefania, Ansotegui, Ignacio, Assa'ad, Amal H., Bahna, Sami L., Canani, Roberto Berni, Bozzola, Martin, Chu, Derek K., Dahdah, Lamia, Dupont, Christophe, Dziechciarz, Piotr, Ebisawa, Motohiro, Galli, Elena, Horvath, Andrea, Kamenwa, Rose, Lack, Gideon, Li, Haiqi, Martelli, Alberto, Nowak-Węgrzyn, Anna, Papadopoulos, Nikolaos G., Pawankar, Ruby, Roldan, Yetiani, Said, Maria, Sánchez-Borges, Mario, Shamir, Raanan, Spergel, Jonathan M., Szajewska, Hania, Terracciano, Luigi, Vandenplas, Yvan, Venter, Carina, Waffenschmidt, Siw, Waserman, Susan, Warner, Amena, Wong, Gary W.K., Fiocchi, Alessandro, and Schünemann, Holger J.

Published
2022
Full Text
View/download PDF

7. GRADE guidance 24 optimizing the integration of randomized and non-randomized studies of interventions in evidence syntheses and health guidelines

Author

Cuello-Garcia, Carlos A., Santesso, Nancy, Morgan, Rebecca L., Verbeek, Jos, Thayer, Kris, Ansari, Mohammed T., Meerpohl, Joerg, Schwingshackl, Lukas, Katikireddi, Srinivasa Vittal, Brozek, Jan L., Reeves, Barnaby, Murad, Mohammad H., Falavigna, Maicon, Mustafa, Reem, Regidor, Deborah L., Alexander, Paul Elias, Garner, Paul, Akl, Elie A., Guyatt, Gordon, and Schünemann, Holger J.

Published
2022
Full Text
View/download PDF

8. A modeling approach to derive baseline risk estimates for GRADE recommendations: Concepts, development, and results of its application to the American Society of Hematology 2019 guidelines on prevention of venous thromboembolism in surgical hospitalized patients

Author

Morgano, Gian Paolo, Wiercioch, Wojtek, Anderson, David R., Brożek, Jan L., Santesso, Nancy, Xie, Feng, Cuker, Adam, Nieuwlaat, Robby, Akl, Elie A., Darzi, Andrea J., Yepes-Nuñez, Juan José, Exteandia-Ikobaltzeta, Itziar, Rahman, Maryam, Rajasekhar, Anita, Rogers, Frederick, Tikkinen, Kari A.O., Yates, Adolph J., Dahm, Philipp, and Schünemann, Holger J.

Published
2021
Full Text
View/download PDF

9. Defining decision thresholds for judgments on health benefits and harms using the Grading of Recommendations Assessment, Development and Evaluation (GRADE) Evidence to Decision (EtD) frameworks: a protocol for a randomised methodological study (GRADE-THRESHOLD)

Author

Morgano, Gian Paolo, primary, Mbuagbaw, Lawrence, additional, Santesso, Nancy, additional, Xie, Feng, additional, Brozek, Jan L, additional, Siebert, Uwe, additional, Bognanni, Antonio, additional, Wiercioch, Wojtek, additional, Piggott, Thomas, additional, Darzi, Andrea J, additional, Akl, Elie A, additional, Verstijnen, Ilse M, additional, Parmelli, Elena, additional, Saz-Parkinson, Zuleika, additional, Alonso-Coello, Pablo, additional, and Schünemann, Holger J, additional

Published
2022
Full Text
View/download PDF

11. World Allergy Organization (WAO) Diagnosis and Rationale for Action against Cow's Milk Allergy (DRACMA) Guideline update - XIV - Recommendations on CMA immunotherapy

Author

Jan L. Brozek, Ramon T. Firmino, Antonio Bognanni, Stefania Arasi, Ignacio Ansotegui, Amal H. Assa'ad, Sami L. Bahna, Roberto Berni Canani, Martin Bozzola, Derek K. Chu, Lamia Dahdah, Christophe Dupont, Piotr Dziechciarz, Motohiro Ebisawa, Elena Galli, Andrea Horvath, Rose Kamenwa, Gideon Lack, Haiqi Li, Alberto Martelli, Anna Nowak-Węgrzyn, Nikolaos G. Papadopoulos, Ruby Pawankar, Yetiani Roldan, Maria Said, Mario Sánchez-Borges, Raanan Shamir, Jonathan M. Spergel, Hania Szajewska, Luigi Terracciano, Yvan Vandenplas, Carina Venter, Siw Waffenschmidt, Susan Waserman, Amena Warner, Gary W.K. Wong, Alessandro Fiocchi, Holger J. Schünemann, Clinical sciences, Growth and Development, Pediatrics, Brozek, Jan L, Firmino, Ramon T, Bognanni, Antonio, Arasi, Stefania, Ansotegui, Ignacio, Assa'Ad, Amal H, Bahna, Sami L, Canani, Roberto Berni, Bozzola, Martin, Chu, Derek K, Dahdah, Lamia, Dupont, Christophe, Dziechciarz, Piotr, Ebisawa, Motohiro, Galli, Elena, Horvath, Andrea, Kamenwa, Rose, Lack, Gideon, Li, Haiqi, Martelli, Alberto, Nowak-Węgrzyn, Anna, Papadopoulos, Nikolaos G, Pawankar, Ruby, Roldan, Yetiani, Said, Maria, Sánchez-Borges, Mario, Shamir, Raanan, Spergel, Jonathan M, Szajewska, Hania, Terracciano, Luigi, Vandenplas, Yvan, Venter, Carina, Waffenschmidt, Siw, Waserman, Susan, Warner, Amena, Wong, Gary W K, Fiocchi, Alessandro, and Schünemann, Holger J

Subjects
Pulmonary and Respiratory Medicine, GRADE, Nutrition and Dietetics, Immunology, food and beverages, gastroenterology, Immunology and Allergy, immunotherapy, Pediatrics, Perinatology, and Child Health, milk allergy, Practice Guidelines
Abstract

Background: The prevalence of cow's milk allergy (CMA) is approximately 2-4.5% in infants and less than 0.5% in adults. Most children outgrow cow's milk allergy in early childhood, particularly that to the baked milk products. Immunotherapy with unheated cow's milk has been used as a treatment option for those who have not yet outgrown CMA, but the benefits must be balanced with the adverse effects. Objective: These evidence-based guidelines from the World Allergy Organization (WAO) intend to support patients, clinicians, and others in decisions about the use of oral and epicutaneous immunotherapy for the treatment of IgE-mediated CMA. Methods: WAO formed a multidisciplinary guideline panel balanced to include the views of all stakeholders and to minimize potential biases from competing interests. The McMaster University GRADE Centre supported the guideline-development process, including updating or performing systematic evidence reviews. The panel prioritized clinical questions and outcomes according to their importance for clinicians and patients. The Grading of Recommendations Assessment, Development and Evaluation (GRADE) approach was used, including GRADE Evidence-to-Decision frameworks, which were subject to public comment. Results: After a careful review of the summarized evidence and thorough discussions the WAO guideline panel suggests: a) using oral immunotherapy with unheated cow's milk in those individuals with confirmed IgE-mediated CMA who value the ability to consume controlled quantities of milk more than avoiding the large adverse effects of therapy, b) not using oral immunotherapy with unheated cow's milk in those who value avoiding large adverse effects of therapy more than the ability to consume controlled quantities of milk, c) using omalizumab in those starting oral immunotherapy with unheated cow's milk, d) not using oral immunotherapy with baked cow's milk in those who do not tolerate both unheated and baked milk, and e) not using epicutaneous immunotherapy outside of a research setting. The recommendations are labeled "conditional" due to the low certainty about the health effects based on the available evidence. Conclusions: Clinicians, patients, and their family members might want to discuss all the potential desirable and undesirable effects of oral immunotherapy for IgE-mediated CMA and integrate them with the patients' values and preferences before deciding on a treatment option. More robust research is needed to determine with greater certainty which interventions are likely to be the most beneficial with the least harms, and to develop safer, low-cost, and equitable treatments.

Published
2022

12. ROBVALU: a tool for assessing risk of bias in studies about people's values, utilities, or importance of health outcomes.

Author

Karam SG, Zhang Y, Pardo-Hernandez H, Siebert U, Koopman L, Noyes J, Tarride JE, Stevens AL, Welch V, Saz-Parkinson Z, Ens B, Devji T, Xie F, Hazlewood G, Mbuagbaw L, Alonso-Coello P, Brozek JL, and Schünemann HJ

Subjects
Humans, Outcome Assessment, Health Care, Risk Assessment methods, Bias
Abstract

Competing Interests: Competing interests: All authors have completed the ICMJE uniform disclosure form at www.icmje.org/disclosure-of-interest/ and declare: support from the Canadian Institutes of Health Research for the submitted work; no financial relationships with any organisations that might have an interest in the submitted work in the previous three years; no other relationships or activities that could appear to have influenced the submitted work.

Published
2024
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results